BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 26, 2013
View Archived Issues
Researchers at Janssen R&D Ireland divulge novel antibacterial agents
Read More
Purdue Pharma prepares new TRPV1 antagonists
Read More
Sihuan Pharmaceutical cleared to conduct study of DPP IV inhibitor in China
Read More
BioMarin presents clinical results for two novel enzyme replacement therapies
Read More
Shimojani acquires exclusive worldwide license to new stroke therapy
Read More
Okairos commences phase I trial of RSV vaccine
Read More
Boehringer Ingelheim describes antidote to dabigatran
Read More
Dual oxidase 1 linked to reactive oxygen species release during ischemia
Read More
ACE gene polymorphism studied in Pompe's disease response to treatment
Read More
New antibacterial agents patented by Actelion Pharmaceuticals
Read More
Tempero Pharmaceuticals divulges novel RORgamma modulators
Read More
Institute for OneWorld Health presents new CFTR channel inhibitors
Read More
New study evaluates CNDO-201 in psoriasis
Read More
Cubist Pharmaceuticals and Adynxx enter acquisition agreement
Read More
Phase III DISCOVER 2 study in ABSSSI meets endpoints
Read More
Ampio Pharmaceuticals modifies Ampion IND to include a dose-escalation study
Read More
First patient dosed in phase Ib study of AVX-470 in ulcerative colitis
Read More
Ligand receives milestone payment from RE-021 collaboration
Read More
MediciNova's MN-166 gets fast track designation from FDA
Read More
SBC-103 shows dose-dependent HSD reductions in MPS-III B mouse model
Read More
Regorafenib granted priority review in Japan
Read More
FDA grants QIDP and fast track designations to Furiex's broad-spectrum antibiotic
Read More
LEO Pharma and 4SC Discovery enter research and license agreement
Read More
Regeneron presents first-in-human results for dupilumab
Read More
Mirabegron launched in the U.K. for treatment of overactive bladder
Read More
Dynavax Technologies receives complete response letter for Heplisav
Read More